![Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America : Volume 43-3, Hardback Book Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America : Volume 43-3, Hardback Book](http://speedyhen.dmmserver.com/media/640/97803233/9780323323253.jpg)
Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America : Volume 43-3 Hardback
by Edward V., MD (Mayo Clinic, Rochester, MN) Loftus Jr
Part of the The Clinics: Internal Medicine series
Hardback
- Information
Description
By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease.
Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug.
Furthermore, as of this writing, we have five other biologic agents approved for either Crohn disease or ulcerative colitis, and there are many more molecules currently in drug development for these indications.
In this issue,the Editors have assembled a collection of experts to provide the most cutting-edge information on the status of biologic therapy for inflammatory bowel disease.
Information
-
Available to Order - This title is available to order, with delivery expected within 2 weeks
- Format:Hardback
- Publisher:Elsevier - Health Sciences Division
- Publication Date:27/03/2015
- Category:
- ISBN:9780323323253
Information
-
Available to Order - This title is available to order, with delivery expected within 2 weeks
- Format:Hardback
- Publisher:Elsevier - Health Sciences Division
- Publication Date:27/03/2015
- Category:
- ISBN:9780323323253